142 related articles for article (PubMed ID: 34049982)
21. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
Vargas HA; Wassberg C; Fox JJ; Wibmer A; Goldman DA; Kuk D; Gonen M; Larson SM; Morris MJ; Scher HI; Hricak H
Radiology; 2014 Apr; 271(1):220-9. PubMed ID: 24475817
[TBL] [Abstract][Full Text] [Related]
22. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of
Cysouw MCF; Kramer GM; Heijtel D; Schuit RC; Morris MJ; van den Eertwegh AJM; Voortman J; Hoekstra OS; Oprea-Lager DE; Boellaard R
EJNMMI Res; 2019 Jul; 9(1):70. PubMed ID: 31363939
[TBL] [Abstract][Full Text] [Related]
24. Healthy Tissue Uptake of
Jansen BHE; Kramer GM; Cysouw MCF; Yaqub MM; de Keizer B; Lavalaye J; Booij J; Vargas HA; Morris MJ; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2019 Aug; 60(8):1111-1117. PubMed ID: 30630941
[TBL] [Abstract][Full Text] [Related]
25. Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.
Ackermann U; Lewis JS; Young K; Morris MJ; Weickhardt A; Davis ID; Scott AM
J Labelled Comp Radiopharm; 2016 Aug; 59(10):424-8. PubMed ID: 27378195
[TBL] [Abstract][Full Text] [Related]
26. Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer.
Kairemo K; Hodolic M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175938
[TBL] [Abstract][Full Text] [Related]
27. The Predictive Value of Early Changes in
He M; Liu C; Shi Q; Sun Y; Zhang Y; Xu X; Yuan H; Zhang Y; Liu Y; Liu G; Di G; Yang Z; Wang Z; Shao Z
Oncologist; 2020 Nov; 25(11):927-936. PubMed ID: 32272493
[TBL] [Abstract][Full Text] [Related]
28. A Randomized Feasibility Study of
Chae SY; Kim SB; Ahn SH; Kim HO; Yoon DH; Ahn JH; Jung KH; Han S; Oh SJ; Lee SJ; Kim HJ; Son BH; Gong G; Lee HS; Moon DH
J Nucl Med; 2017 Apr; 58(4):563-568. PubMed ID: 27688475
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.
Pandit-Taskar N; Veach DR; Fox JJ; Scher HI; Morris MJ; Larson SM
J Nucl Med; 2016 Oct; 57(Suppl 3):73S-78S. PubMed ID: 27694177
[TBL] [Abstract][Full Text] [Related]
30. Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT.
Fox JJ; Autran-Blanc E; Morris MJ; Gavane S; Nehmeh S; Van Nuffel A; Gönen M; Schöder H; Humm JL; Scher HI; Larson SM
J Nucl Med; 2011 Nov; 52(11):1727-32. PubMed ID: 21984797
[TBL] [Abstract][Full Text] [Related]
31. 18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET).
Bertolini R; Goepfert C; Andrieu T; Nichols S; Walter MA; Frey FJ; McCammon JA; Frey BM
Prostate; 2015 Mar; 75(4):348-59. PubMed ID: 25358634
[TBL] [Abstract][Full Text] [Related]
32. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
33. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
[TBL] [Abstract][Full Text] [Related]
34. Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.
van Kruchten M; de Vries EF; Arts HJ; Jager NM; Bongaerts AH; Glaudemans AW; Hollema H; de Vries EG; Hospers GA; Reyners AK
J Nucl Med; 2015 Jan; 56(1):50-5. PubMed ID: 25476534
[TBL] [Abstract][Full Text] [Related]
35. Early SUV
Zhang J; Shi X; Xiao Y; Ma C; Cao G; Liu Y; Li Y
Quant Imaging Med Surg; 2021 May; 11(5):1680-1691. PubMed ID: 33936956
[TBL] [Abstract][Full Text] [Related]
36. Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
Groheux D; Sanna A; Majdoub M; de Cremoux P; Giacchetti S; Teixeira L; Espié M; Merlet P; de Roquancourt A; Visvikis D; Hatt M; Resche-Rigon M; Hindié E
J Nucl Med; 2015 Jun; 56(6):824-31. PubMed ID: 25883123
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.
Gemignani ML; Patil S; Seshan VE; Sampson M; Humm JL; Lewis JS; Brogi E; Larson SM; Morrow M; Pandit-Taskar N
J Nucl Med; 2013 Oct; 54(10):1697-702. PubMed ID: 23970364
[TBL] [Abstract][Full Text] [Related]
38. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
[TBL] [Abstract][Full Text] [Related]
39. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
40. Prospective Study of Serial
Peterson LM; O'Sullivan J; Wu QV; Novakova-Jiresova A; Jenkins I; Lee JH; Shields A; Montgomery S; Linden HM; Gralow J; Gadi VK; Muzi M; Kinahan P; Mankoff D; Specht JM
J Nucl Med; 2018 Dec; 59(12):1823-1830. PubMed ID: 29748233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]